Illumina
San Diego · Founded 1998
About Illumina
Illumina is an innovative technology and revolutionary assay aiming to analyze genetic variation and function. These studies help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, it strives to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Company Facts
- Founded: 1998
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 5,001 – 10,000
- Estimated revenue: $1M – $10M
- Total funding: $1.3B
- Funding stage: IPO
- Last round: Post-IPO Debt (Sep 2024)
- Ticker: nasdaq:ILMN
- Website: illumina.com
- Phone: 858.202.4500
Industries & Categories
Biotechnology, Genetics, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/illumina-29238 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.